Evotec
Jeff Naroian has extensive experience in business development. Jeff started their career at Pharm-Eco in 1994, where they held multiple roles in business development until 2000. From 2000 to 2001, they worked as a Business Development Manager at UCB Bioproducts. Since 2001, they have been with Evotec, initially as a Vice President of Business Development and currently as a Senior Vice President of Business Development.
Jeff Naroian attended Merrimack College from 1991 to 1995, where they studied Organic Chemistry. Jeff later pursued a Master of Business Administration (M.B.A.) at D'Amore-McKim School of Business at Northeastern University.
This person is not in the org chart
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.